Skip Navigation

If you wish to respond to a paper or other item already published in the BJA, please go to the abstract/full text version of that item and click on the link "E-Letters: Submit a response to the article".

Electronic Letters to:

Correspondence:
J. Moon and J. Cros
Role of dantrolene in the management of the acute toxic effects of Ecstasy (MDMA)
Br. J. Anaesth. 2007; 99: 146 [Full text] [PDF]
*E-letters: Submit a response to this article

Electronic letters published:

[Read E-letter] Acetaminophen versus dantrolene as antipyretic
Julian P Stone   (11 July 2007)

Acetaminophen versus dantrolene as antipyretic 11 July 2007
  Top
Julian P Stone,
Anaesthetic Consultant

Send letter to journal:
Re: Acetaminophen versus dantrolene as antipyretic

Anaesthetic Department Great Western Hospital Swindon Wilts SN3 6BB

5/7/7 Editor

I should like to comment on the case discussed by Moon and Cros about the use of dantrolene in the management of Ecstasy (3,4- methylenedioxymetamphetamine,MDMA) induced hyperthermia [1].

Although the dantolene given to the patient almost certainly reduced the muscle rigidity, it is not clear how the effect of it on the temperature can be separated from that of the acetaminophen 1 gram per rectum since only a short time elapsed after the acetaminophen administration before the dantrolene was given.

Rectal acetaminophen has variable absorption but its peak plasma level certainly is longer than 45 min. Beck and colleagues found that peak plasma levels were 4.2 hours and 3.6 hours after 20mg/kg and 40 mg/kg rectal acetaminophen respectively [2].

Intravenous acetaminophen is becoming increasingly available and will produce quicker and more predictable peak plasma levels as well as being less expensive.

Dr Julian P Stone drjpstone@hotmail.com

1. Moon J,Cros J. Br J Anaesth2007;99:146 2. Beck DH,Schenk MR,Hagemann K,Doepfmer UR,Kox WJ.Anesth Analg 2000;90:431-6

Conflict of Interest:

None declared